(Q35003023)
Statements
1 reference
A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma (English)
1 reference
Bernard Escudier
1 reference
Chrystelle Brignone
1 reference
Caroline Grygar
1 reference
Manon Marcu
1 reference
Frédéric Triebel
1 reference
15 September 2009
1 reference
1 reference
15
1 reference
19
1 reference
6225-6231
1 reference
Identifiers
1 reference
1 reference